BIOSECURE Act 2025 update: what it means for biopharma outsourcing and what to do now

Latest Blogs

Infographic showing gene editing applications across the drug development pipeline.

Gene editing in 2025: from CRISPR to next generation platforms

AI drug discovery workflow for small molecule design

AI Drug Discovery: The Future of Small Molecule Design

Tirbanibulin and targeted dermal delivery in topical drug development

Therapeutics 2.0: Veterinary Oncology and Peptide Conjugates for Companion Animal Health

Current Toxicology Developments: Advancing Digital Pathology in Predictive, Mechanistic, and Human-Relevant Safety Science

GXP compliance balancing speed and quality in outsourced R&D

Speed vs. quality: balancing timelines in outsourced R&D with GXP compliance

To view or email, Please share your details view

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details